Accent Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of ATX-559 and Chief ...
Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer ...
BBC19 小时
Horse Racing UK & Ireland Results
© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.